Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial

D. Rayson; T. M. Suter; C. Jackisch; S. Van der Vegt; B. Bermejo; J. Van den Bosch; G. L. Vivanco; A. M. Van Gent; H. Wildiers; A. Torres; L. Provencher; M. Temizkan; J. Chirgwin; J. L. Canon; G. Ferrandina; S. Srinivasan; L. Zhang; D. J. Richel

doi:10.1093/annonc/mdr519

Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial

D. Rayson, T. M. Suter, C. Jackisch, S. Van der Vegt, B. Bermejo, J. Van den Bosch, G. L. Vivanco, A. M. Van Gent, H. Wildiers, A. Torres, L. Provencher, M. Temizkan, J. Chirgwin, J. L. Canon, G. Ferrandina, S. Srinivasan, L. Zhang, D. J. Richel

Computer Science

科研成果: 期刊稿件 › 文章 › 同行评审

36 引用（Scopus）

源语言	英语
页（从-至）	1780-1788
页数	9
期刊	Annals of Oncology
卷	23
期	7
DOI	https://doi.org/10.1093/annonc/mdr519
出版状态	已出版 - 7月 2012

!!!ASJC Scopus Subject Areas

血液学
肿瘤学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1093/annonc/mdr519

其它文件与链接

引用此

Rayson, D., Suter, T. M., Jackisch, C., Van der Vegt, S., Bermejo, B., Van den Bosch, J., Vivanco, G. L., Van Gent, A. M., Wildiers, H., Torres, A., Provencher, L., Temizkan, M., Chirgwin, J., Canon, J. L., Ferrandina, G., Srinivasan, S., Zhang, L., & Richel, D. J. (2012). Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial. Annals of Oncology, 23(7), 1780-1788. https://doi.org/10.1093/annonc/mdr519

Rayson, D, Suter, TM, Jackisch, C, Van der Vegt, S, Bermejo, B, Van den Bosch, J, Vivanco, GL, Van Gent, AM, Wildiers, H, Torres, A, Provencher, L, Temizkan, M, Chirgwin, J, Canon, JL, Ferrandina, G, Srinivasan, S, Zhang, L & Richel, DJ 2012, 'Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial', Annals of Oncology, 卷 23, 号码 7, 页码 1780-1788. https://doi.org/10.1093/annonc/mdr519

@article{5631d0116c1849df887c75b367c7072a,

title = "Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial",

keywords = "Adjuvant therapy, Anthracyclines, Breast cancer, Cardiotoxicity, Pegylated liposomal doxorubicin, Trastuzumab",

author = "D. Rayson and Suter, {T. M.} and C. Jackisch and {Van der Vegt}, S. and B. Bermejo and {Van den Bosch}, J. and Vivanco, {G. L.} and {Van Gent}, {A. M.} and H. Wildiers and A. Torres and L. Provencher and M. Temizkan and J. Chirgwin and Canon, {J. L.} and G. Ferrandina and S. Srinivasan and L. Zhang and Richel, {D. J.}",

year = "2012",

month = jul,

doi = "10.1093/annonc/mdr519",

language = "English",

volume = "23",

pages = "1780--1788",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab

T2 - A randomized phase II trial

AU - Rayson, D.

AU - Suter, T. M.

AU - Jackisch, C.

AU - Van der Vegt, S.

AU - Bermejo, B.

AU - Van den Bosch, J.

AU - Vivanco, G. L.

AU - Van Gent, A. M.

AU - Wildiers, H.

AU - Torres, A.

AU - Provencher, L.

AU - Temizkan, M.

AU - Chirgwin, J.

AU - Canon, J. L.

AU - Ferrandina, G.

AU - Srinivasan, S.

AU - Zhang, L.

AU - Richel, D. J.

PY - 2012/7

Y1 - 2012/7

KW - Adjuvant therapy

KW - Anthracyclines

KW - Breast cancer

KW - Cardiotoxicity

KW - Pegylated liposomal doxorubicin

KW - Trastuzumab

UR - http://www.scopus.com/inward/record.url?scp=84864302673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864302673&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdr519

DO - 10.1093/annonc/mdr519

M3 - Article

C2 - 22056854

AN - SCOPUS:84864302673

SN - 0923-7534

VL - 23

SP - 1780

EP - 1788

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

ER -

Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此